A Retrospective Analysis: the Influence of Caltrate Supplement on the Effect of Mesalazine in Ulcerative Colitis
Status:
Completed
Trial end date:
2021-03-31
Target enrollment:
Participant gender:
Summary
Aims:Retrospectively observe the effects of Caltrate supplementation on the clinical effect
of mesalazine in patients with ulcerative colitis.
Design: From January 2015 to December 2020, through retrieving the clinical database of the
Second Affiliated Hospital of Wenzhou Medical University, patients with active UC who
accepted mesalazine treatment were enrolled. According to whether Caltrate was supplemented
at the same time, the patients were divided into supplementary group and non-supplementary
group. The modified Mayo score and several laboratory indicators were compared between the
two groups.
Details
Lead Sponsor:
Second Affiliated Hospital of Wenzhou Medical University
Treatments:
Calcium Carbonate Ergocalciferols Vitamin D Vitamins